Fabrizio Ecca

The Genotype for <i><scp>DPYD</scp></i> Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice

Giuseppe Toffoli, Federico Innocenti, Jerry Polesel et al. · Clinical Pharmacology & Therapeutics · 2018 · 53 citations

Medicine, Oncology, Pharmacology +17

Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity

Vasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte et al. · The American Journal of Human Genetics · 2019 · 52 citations · Full text

Medicine, Oncology, Pharmacoeconomics +14

Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk

Elena De Mattia, Marco Silvestri, Jerry Polesel et al. · Biomedicine & Pharmacotherapy · 2022 · 40 citations · Full text

Medicine, Molecular Genetics, Pharmacology +17

Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects

Concetta Russo Spena, Lucia De Stefano, Giulio Poli et al. · Journal of Cellular Physiology · 2019 · 31 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Clonal Evolution of TP53 c.375+1G&gt;A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)

Marica Garziera, Erika Cecchin, Giorgio Giorda et al. · Cells · 2019 · 13 citations · Full text

Medicine, Molecular Genetics, Oncology +17